Can a common drug boost Chemo's power against Hard-to-Treat leukemia?
Disease control
Not yet recruiting
This trial is testing whether adding hydroxyurea to a standard chemotherapy combination can improve outcomes for adults with acute myeloid leukemia (AML) that has returned or not responded to treatment. The study is conducted in two parts: first to find the safest dose of hydroxy…
Phase: PHASE1, PHASE2 • Sponsor: Christer C Nilsson • Aim: Disease control
Last updated Aug 18, 2026 05:00 UTC